| IVVD |
Invivyd, Inc. |
19 Nov 2025 |
1 |
+$125,000 |
4 |
Director |
20 Nov 2025, 16:22 |
| VCEL |
Vericel Corp |
10 Nov 2025 |
3 |
-$251,720 |
4 |
Director |
12 Nov 2025, 16:06 |
| VCEL |
Vericel Corp |
06 Aug 2025 |
3 |
-$232,120 |
4 |
Director |
08 Aug 2025, 16:05 |
| IVVD |
Invivyd, Inc. |
20 May 2025 |
1 |
$0 |
4 |
Director |
22 May 2025, 16:14 |
| VCEL |
Vericel Corp |
07 May 2025 |
3 |
-$260,540 |
4 |
Director |
09 May 2025, 16:05 |
| VCEL |
Vericel Corp |
30 Apr 2025 |
4 |
$0 |
4 |
Director |
02 May 2025, 16:07 |
| VCEL |
Vericel Corp |
12 Feb 2025 |
6 |
-$363,050 |
4 |
Director |
14 Feb 2025, 16:05 |
| VCEL |
Vericel Corp |
13 Nov 2024 |
3 |
-$362,600 |
4 |
Director |
15 Nov 2024, 16:05 |
| VCEL |
Vericel Corp |
07 Aug 2024 |
6 |
-$295,400 |
4 |
Director |
09 Aug 2024, 16:05 |
| IVVD |
Invivyd, Inc. |
21 May 2024 |
1 |
$0 |
4 |
Director |
23 May 2024, 18:26 |
| IVVD |
Invivyd, Inc. |
21 May 2024 |
0 |
$0 |
3 |
Director |
23 May 2024, 17:07 |
| VCEL |
Vericel Corp |
01 May 2024 |
4 |
$0 |
4 |
Director |
03 May 2024, 16:06 |
| /report/000089924323019494-mclaughlin-kevin-f-2023-09-25 |
Decibel Therapeutics, Inc. |
25 Sep 2023 |
3 |
$0 |
4 |
Director |
25 Sep 2023, 16:28 |
| /report/000095017023027990-mclaughlin-kevin-f-2023-06-13 |
Decibel Therapeutics, Inc. |
13 Jun 2023 |
2 |
$0 |
4 |
Director |
14 Jun 2023, 16:37 |
| VCEL |
Vericel Corp |
03 May 2023 |
2 |
$0 |
4 |
Director |
05 May 2023, 16:04 |
| VCEL |
Vericel Corp |
27 Apr 2023 |
2 |
$0 |
4 |
Director |
28 Apr 2023, 16:04 |
| /report/000089924322033453-mclaughlin-kevin-f-2022-10-10 |
Decibel Therapeutics, Inc. |
10 Oct 2022 |
1 |
$0 |
4 |
Director |
12 Oct 2022, 08:23 |
| /report/000089924322033451-mclaughlin-kevin-f-2022-10-10 |
Decibel Therapeutics, Inc. |
10 Oct 2022 |
0 |
$0 |
3 |
Director |
12 Oct 2022, 08:13 |
| VCEL |
Vericel Corp |
27 Apr 2022 |
4 |
$0 |
4 |
Director |
29 Apr 2022, 16:10 |
| /report/000110465921142266-mclaughlin-kevin-f-2021-11-19 |
ACCELERON PHARMA INC |
19 Nov 2021 |
6 |
$0 |
4 |
SVP, CFO and Treasurer |
22 Nov 2021, 08:03 |
| /report/000117911021008935-mclaughlin-kevin-f-2021-09-23 |
ACCELERON PHARMA INC |
23 Sep 2021 |
13 |
-$3,011,252 |
4 |
SVP, CFO and Treasurer |
24 Sep 2021, 19:36 |